VESICARE LS Drug Patent Profile
✉ Email this page to a colleague
When do Vesicare Ls patents expire, and when can generic versions of Vesicare Ls launch?
Vesicare Ls is a drug marketed by Astellas and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has twenty-three patent family members in twenty-one countries.
The generic ingredient in VESICARE LS is solifenacin succinate. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vesicare Ls
A generic version of VESICARE LS was approved as solifenacin succinate by TEVA PHARMS USA on April 2nd, 2014.
Summary for VESICARE LS
International Patents: | 23 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 67 |
Patent Applications: | 1,864 |
Drug Prices: | Drug price information for VESICARE LS |
DailyMed Link: | VESICARE LS at DailyMed |
Recent Clinical Trials for VESICARE LS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hikma Pharma | Phase 1 |
Genuine Research Center, Egypt | Phase 1 |
Brigitte Schürch | Phase 4 |
Pharmacology for VESICARE LS
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for VESICARE LS
Paragraph IV (Patent) Challenges for VESICARE LS
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VESICARE LS | Oral Suspension | solifenacin succinate | 1 mg/mL | 209529 | 1 | 2021-05-27 |
US Patents and Regulatory Information for VESICARE LS
VESICARE LS is protected by one US patents.
Patents protecting VESICARE LS
Pharmaceutical composition comprising solifenacin
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | VESICARE LS | solifenacin succinate | SUSPENSION;ORAL | 209529-001 | May 26, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VESICARE LS
See the table below for patents covering VESICARE LS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Taiwan | 201208684 | Pharmaceutical composition comprising solifenacin | ⤷ Try a Trial |
South Africa | 201208762 | PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN | ⤷ Try a Trial |
Lithuania | 2572717 | ⤷ Try a Trial | |
Portugal | 2572717 | ⤷ Try a Trial | |
Mexico | 2012013328 | COMPOSICION FARMACEUTICA QUE CONTIENE SOLIFENACINA. (PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN.) | ⤷ Try a Trial |
Canada | 2799942 | COMPOSITION PHARMACEUTIQUE CONTENANT DE LA SOLIFENACINE (PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN) | ⤷ Try a Trial |
Japan | WO2011145642 | ソリフェナシン含有医薬組成物 | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VESICARE LS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0801067 | C00801067/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: SOLIFENACIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57203 12.05.2006 |
0801067 | SPC/GB04/029 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: SOLIFENACIN AND/OR PHARMACEUTICALLY ACTIVE SALT THEREOF; REGISTERED: NL RVG 29151 20031216; NL RVG 29152 20031216; UK PL 00166/0197 20040816; UK PL 0016/0198 20040816 |
0801067 | 04C0032 | France | ⤷ Try a Trial | PRODUCT NAME: SUCCINATE DE SOLIFENACINE; NAT. REGISTRATION NO/DATE: NL 30 109 20040816; FIRST REGISTRATION: NL - RVG 29 151 20031216 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |